#MacroGenics

MacroGenics Files DEF 14A on Apr 8, 2026 MacroGenics (MGNX) filed a Form DEF 14A on Apr 8, 2026 (Investing.com); the proxy starts the formal voting process and could influence board composition and equity authorizations.

MacroGenics Files DEF 14A on Apr 8, 2026: MacroGenics (MGNX) filed a Form DEF 14A on Apr 8, 2026 (Investing.com); the proxy starts the formal voting process and could influence board composition and equity… 👈 Read full analysis #MacroGenics #MGNX #ProxyVoting #ShareholderRights #CorporateGovernance

MacroGenics And 2 Other Promising Penny Stocks To Consider - Yahoo Finance MacroGenics And 2 Other Promising Penny Stocks To Consider  Yahoo Finance

Click Subscribe #Investing #PennyStocks #StockMarket #Finance #MacroGenics

MacroGenics stock surges as it sells ZYNYZ drug royalty rights This surge followed the announcement that MacroGenics will sell its royalty rights on global net sales of its drug ZYNYZ to Sagard, an alternative asset management firm. The terms of the deal involve Sagard paying MacroGenics an upfront sum of $70 million. Once Sagard collects $140 million in royalties from ZYNYZ, MacroGenics will then start collecting all future royalties from the drug. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. MGNX: A Bull or Bear Market Play? Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if MGNX is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.

Click Subscribe #MacroGenics #ZYNYZ #StockMarket #Pharmaceuticals #Investing